Obermatt
See Similar Stocks →

CYBERDYNE

TYO:7779 · JP3311530004
Health Care Equipment & SuppliesSmall

360

73
Profit price9
Owner Earnings Yield72
Dividend Yield1
Price/Sales5
EV / Gross Profit11
Price/Book52
Return on Capital53
Cash Return on Capital70
Return on Equity61
EBIT Margin29
Gross Profitability4
Cash Conversion51
Accruals57
Owner Earnings Margin94
Sales growth86
Profit Growth1
Owner Earnings Growth100
Reinvestment34
Price momentum96
Debt load93
Refinancing60
Debt Payback100
Liquidity6
Analyst ratings28
Opinion Changes50
Price Target Upside8
Market mood59
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

CYBERDYNE doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryJapan
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeTSE
Founded2004
Employees62
Websitecyberdyne.jp
ISINJP3311530004
Last UpdateApr 2, 2026
Index & Theme
Health DiagnosticsAssistive TechnologyOrthopaedicsNeurologyNeuroscienceBiomedical EngineeringHardwareLogisticsMedicalRoboticsSoftware

Description

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare. The company’s core philosophy centers on the integration of robotics with health care to create innovative solutions tha…

Analysis

Middle-of-the-road

CYBERDYNE Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 70.8× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone.

The trajectory is solid and the balance sheet is sturdy. The company scores 6/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
21
2023202420252026

All-time high

37

Jan 2025

All-time low

6

Mar 2026

Average rank

17

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
5
19
19
5
Price/Earnings
1
3
91
1
Price/Book
52
80
83
72
Dividend Yield
1
1
1
1
Value (overall)
12
29
34
11

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare CYBERDYNE with its peers
Solasto
TYO:6197
59
CountryJapan
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Prenetics Global
NMQ:PRE
52
CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Australian Clinical Labs
ASX:ACL
65
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Integral Diagnostics
ASX:IDX
45
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Ramsay Health Care
ASX:RHC
15
CountryAustralia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Apex Biotechnology
TAI:1733
72
CountryTaiwan
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →